151 related articles for article (PubMed ID: 859645)
1. The effect of 5,6-trans-25-hydroxycholecalciferol in relative vitamin D resistancy.
Kraft D; Offermann G
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):75-80. PubMed ID: 859645
[TBL] [Abstract][Full Text] [Related]
2. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
Jorgensen H; Vogt JH
Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
[TBL] [Abstract][Full Text] [Related]
3. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
[No Abstract] [Full Text] [Related]
4. Vitamin D metabolism.
Holick MF; DeLuca HF
Annu Rev Med; 1974; 25():349-67. PubMed ID: 4363209
[No Abstract] [Full Text] [Related]
5. I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
Catto GR; MacLeod M; Pelc B; Kodicek E
Br Med J; 1975 Jan; 1(5948):12-4. PubMed ID: 1120218
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the 5,6-cis and 5,6-trans isomers of 25-hydroxyvitamin D3 in chronic hypoparathyroidism.
Offermann G; Kraft D
Acta Endocrinol (Copenh); 1977 Dec; 86(4):784-93. PubMed ID: 579038
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol in disorders of bone and calcium metabolism.
Riggs BL
Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
[No Abstract] [Full Text] [Related]
9. Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.
von Herrath D; Schaefer K; Kraft D; Grigoleit HG; Koeppe P
Klin Wochenschr; 1973 Oct; 51(19):979-81. PubMed ID: 4762587
[No Abstract] [Full Text] [Related]
10. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
11. Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man.
Brickman AS; Coburn JW; Norman AW
N Engl J Med; 1972 Nov; 287(18):891-5. PubMed ID: 4342432
[No Abstract] [Full Text] [Related]
12. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
Vattimo A
Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
[TBL] [Abstract][Full Text] [Related]
13. Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.
Hirooka M; Wako H; Kaneko C; Ishikawa M; Sasaki S
J Nutr Sci Vitaminol (Tokyo); 1975; 21(4):277-85. PubMed ID: 1214180
[TBL] [Abstract][Full Text] [Related]
14. The treatment of hypoparathyroidism with 1alpha-hydroxycholecalciferol.
Brenton DP; Dent CE; Gertner JM
Calcif Tissue Res; 1977 May; 22 Suppl():545-52. PubMed ID: 912584
[No Abstract] [Full Text] [Related]
15. Action of 1,25-dihydroxycholecalciferol in uraemia.
Lancet; 1972 Dec; 2(7788):1185-6. PubMed ID: 4117601
[No Abstract] [Full Text] [Related]
16. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
Kiilerich S; Christiansen C; Christensen MS; Naestoft J
Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
[TBL] [Abstract][Full Text] [Related]
17. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW
Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
Pak CY; DeLuca HF; Chavez de los Rios JM; Suda T; Ruskin B; Delea CS
Arch Intern Med; 1970 Aug; 126(2):239-47. PubMed ID: 4317441
[No Abstract] [Full Text] [Related]
19. Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.
Vardi P; Benderly A; Etzioni A; Levy J; Hochberg Z
Eur J Pediatr; 1985 Sep; 144(3):280-2. PubMed ID: 4054169
[TBL] [Abstract][Full Text] [Related]
20. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
Wright DR
N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
